2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane

C163H186BBrF18N18O21Si4 — CID 176535716

IUPAC2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane
SMILESCC1CCC(Oc2ccc(-c3ccc(-c4ncc(C(F)(F)F)[nH]4)cn3)cc2)CC1.CCC1CCC(O)CC1.CCC1CCC(Oc2ccc(-c3ccc(-c4nc(C(F)(F)F)cn4COCC[Si](C)(C)C)cn3)cc2)CC1.CCC1CCC(Oc2ccc(-c3ccc(-c4ncc(C(F)(F)F)[nH]4)cn3)cc2)CC1.C[Si](C)(C)CCOCn1cc(C(F)(F)F)nc1-c1ccc(-c2ccc(O)cc2)nc1.C[Si](C)(C)CCOCn1cc(C(F)(F)F)nc1-c1ccc(-c2ccc(OCc3ccccc3)cc2)nc1.C[Si](C)(C)CCOCn1cc(C(F)(F)F)nc1-c1ccc(Br)nc1.O=C=O.O=C=O.O=C=O.O=C=O.OB(O)c1ccc(OCc2ccccc2)cc1
InChIInChI=1S/C29H38F3N3O2Si.C28H30F3N3O2Si.C23H24F3N3O.C22H22F3N3O.C21H24F3N3O2Si.C15H19BrF3N3OSi.C13H13BO3.C8H16O.4CO2/c1-5-21-6-11-24(12-7-21)37-25-13-8-22(9-14-25)26-15-10-23(18-33-26)28-34-27(29(30,31)32)19-35(28)20-36-16-17-38(2,3)4;1-37(2,3)16-15-35-20-34-18-26(28(29,30)31)33-27(34)23-11-14-25(32-17-23)22-9-12-24(13-10-22)36-19-21-7-5-4-6-8-21;1-2-15-3-8-18(9-4-15)30-19-10-5-16(6-11-19)20-12-7-17(13-27-20)22-28-14-21(29-22)23(24,25)26;1-14-2-7-17(8-3-14)29-18-9-4-15(5-10-18)19-11-6-16(12-26-19)21-27-13-20(28-21)22(23,24)25;1-30(2,3)11-10-29-14-27-13-19(21(22,23)24)26-20(27)16-6-9-18(25-12-16)15-4-7-17(28)8-5-15;1-24(2,3)7-6-23-10-22-9-12(15(17,18)19)21-14(22)11-4-5-13(16)20-8-11;15-14(16)12-6-8-13(9-7-12)17-10-11-4-2-1-3-5-11;1-2-7-3-5-8(9)6-4-7;4*2-1-3/h8-10,13-15,18-19,21,24H,5-7,11-12,16-17,20H2,1-4H3;4-14,17-18H,15-16,19-20H2,1-3H3;5-7,10-15,18H,2-4,8-9H2,1H3,(H,28,29);4-6,9-14,17H,2-3,7-8H2,1H3,(H,27,28);4-9,12-13,28H,10-11,14H2,1-3H3;4-5,8-9H,6-7,10H2,1-3H3;1-9,15-16H,10H2;7-9H,2-6H2,1H3;;;;
InChIKeyKNRUGFJFWPYTAS-UHFFFAOYSA-N
MW3278.41 g/mol
LogP39.68
Rot. Bonds47

About 2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane

2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane (PubChem CID 176535716) has the molecular formula C163H186BBrF18N18O21Si4 and a molecular weight of 3278.41 g/mol. Its IUPAC name is 2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane.

Molecular Properties

Compound Name2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane
PubChem CID176535716
Molecular FormulaC163H186BBrF18N18O21Si4
Molecular Weight3278.41 g/mol
Exact Mass3275.21
IUPAC Name2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane
SMILESCC1CCC(Oc2ccc(-c3ccc(-c4ncc(C(F)(F)F)[nH]4)cn3)cc2)CC1.CCC1CCC(O)CC1.CCC1CCC(Oc2ccc(-c3ccc(-c4nc(C(F)(F)F)cn4COCC[Si](C)(C)C)cn3)cc2)CC1.CCC1CCC(Oc2ccc(-c3ccc(-c4ncc(C(F)(F)F)[nH]4)cn3)cc2)CC1.C[Si](C)(C)CCOCn1cc(C(F)(F)F)nc1-c1ccc(-c2ccc(O)cc2)nc1.C[Si](C)(C)CCOCn1cc(C(F)(F)F)nc1-c1ccc(-c2ccc(OCc3ccccc3)cc2)nc1.C[Si](C)(C)CCOCn1cc(C(F)(F)F)nc1-c1ccc(Br)nc1.O=C=O.O=C=O.O=C=O.O=C=O.OB(O)c1ccc(OCc2ccccc2)cc1
InChIInChI=1S/C29H38F3N3O2Si.C28H30F3N3O2Si.C23H24F3N3O.C22H22F3N3O.C21H24F3N3O2Si.C15H19BrF3N3OSi.C13H13BO3.C8H16O.4CO2/c1-5-21-6-11-24(12-7-21)37-25-13-8-22(9-14-25)26-15-10-23(18-33-26)28-34-27(29(30,31)32)19-35(28)20-36-16-17-38(2,3)4;1-37(2,3)16-15-35-20-34-18-26(28(29,30)31)33-27(34)23-11-14-25(32-17-23)22-9-12-24(13-10-22)36-19-21-7-5-4-6-8-21;1-2-15-3-8-18(9-4-15)30-19-10-5-16(6-11-19)20-12-7-17(13-27-20)22-28-14-21(29-22)23(24,25)26;1-14-2-7-17(8-3-14)29-18-9-4-15(5-10-18)19-11-6-16(12-26-19)21-27-13-20(28-21)22(23,24)25;1-30(2,3)11-10-29-14-27-13-19(21(22,23)24)26-20(27)16-6-9-18(25-12-16)15-4-7-17(28)8-5-15;1-24(2,3)7-6-23-10-22-9-12(15(17,18)19)21-14(22)11-4-5-13(16)20-8-11;15-14(16)12-6-8-13(9-7-12)17-10-11-4-2-1-3-5-11;1-2-7-3-5-8(9)6-4-7;4*2-1-3/h8-10,13-15,18-19,21,24H,5-7,11-12,16-17,20H2,1-4H3;4-14,17-18H,15-16,19-20H2,1-3H3;5-7,10-15,18H,2-4,8-9H2,1H3,(H,28,29);4-6,9-14,17H,2-3,7-8H2,1H3,(H,27,28);4-9,12-13,28H,10-11,14H2,1-3H3;4-5,8-9H,6-7,10H2,1-3H3;1-9,15-16H,10H2;7-9H,2-6H2,1H3;;;;
InChIKeyKNRUGFJFWPYTAS-UHFFFAOYSA-N
XLogP39.68
TPSA506.53 Ų
H-Bond Donors6
H-Bond Acceptors37
Rotatable Bonds47
Heavy Atoms226
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003278.41
LogP ≤ 539.68
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1037

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane?
The IUPAC name of 2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane (CID 176535716) is 2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane.
What is the SMILES notation for 2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane?
The canonical SMILES for 2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane is CC1CCC(Oc2ccc(-c3ccc(-c4ncc(C(F)(F)F)[nH]4)cn3)cc2)CC1.CCC1CCC(O)CC1.CCC1CCC(Oc2ccc(-c3ccc(-c4nc(C(F)(F)F)cn4COCC[Si](C)(C)C)cn3)cc2)CC1.CCC1CCC(Oc2ccc(-c3ccc(-c4ncc(C(F)(F)F)[nH]4)cn3)cc2)CC1.C[Si](C)(C)CCOCn1cc(C(F)(F)F)nc1-c1ccc(-c2ccc(O)cc2)nc1.C[Si](C)(C)CCOCn1cc(C(F)(F)F)nc1-c1ccc(-c2ccc(OCc3ccccc3)cc2)nc1.C[Si](C)(C)CCOCn1cc(C(F)(F)F)nc1-c1ccc(Br)nc1.O=C=O.O=C=O.O=C=O.O=C=O.OB(O)c1ccc(OCc2ccccc2)cc1.
What is the InChIKey of 2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane?
The InChIKey is KNRUGFJFWPYTAS-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H38F3N3O2Si.C28H30F3N3O2Si.C23H24F3N3O.C22H22F3N3O.C21H24F3N3O2Si.C15H19BrF3N3OSi.C13H13BO3.C8H16O.4CO2/c1-5-21-6-11-24(12-7-21)37-25-13-8-22(9-14-25)26-15-10-23(18-33-26)28-34-27(29(30,31)32)19-35(28)20-36-16-17-38(2,3)4;1-37(2,3)16-15-35-20-34-18-26(28(29,30)31)33-27(34)23-11-14-25(32-17-23)22-9-12-24(13-10-22)36-19-21-7-5-4-6-8-21;1-2-15-3-8-18(9-4-15)30-19-10-5-16(6-11-19)20-12-7-17(13-27-20)22-28-14-21(29-22)23(24,25)26;1-14-2-7-17(8-3-14)29-18-9-4-15(5-10-18)19-11-6-16(12-26-19)21-27-13-20(28-21)22(23,24)25;1-30(2,3)11-10-29-14-27-13-19(21(22,23)24)26-20(27)16-6-9-18(25-12-16)15-4-7-17(28)8-5-15;1-24(2,3)7-6-23-10-22-9-12(15(17,18)19)21-14(22)11-4-5-13(16)20-8-11;15-14(16)12-6-8-13(9-7-12)17-10-11-4-2-1-3-5-11;1-2-7-3-5-8(9)6-4-7;4*2-1-3/h8-10,13-15,18-19,21,24H,5-7,11-12,16-17,20H2,1-4H3;4-14,17-18H,15-16,19-20H2,1-3H3;5-7,10-15,18H,2-4,8-9H2,1H3,(H,28,29);4-6,9-14,17H,2-3,7-8H2,1H3,(H,27,28);4-9,12-13,28H,10-11,14H2,1-3H3;4-5,8-9H,6-7,10H2,1-3H3;1-9,15-16H,10H2;7-9H,2-6H2,1H3;;;;.
What are the key properties of 2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane?
2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane has a molecular weight of 3278.41 g/mol, XLogP of 39.68, 47 rotatable bonds, 6 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[2-(6-bromo-3-pyridinyl)-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;tetrakis(carbon dioxide);4-ethylcyclohexan-1-ol;2-[[2-[6-[4-(4-ethylcyclohexyl)oxyphenyl]-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl-trimethylsilane;2-[4-(4-ethylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;2-[4-(4-methylcyclohexyl)oxyphenyl]-5-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridine;(4-phenylmethoxyphenyl)boronic acid;4-[5-[4-(trifluoromethyl)-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]-2-pyridinyl]phenol;trimethyl-[2-[[2-[6-(4-phenylmethoxyphenyl)-3-pyridinyl]-4-(trifluoromethyl)imidazol-1-yl]methoxy]ethyl]silane is sourced from PubChem (CID 176535716), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).